Advances in Clinical Chemistry

Erscheinungsjahr 2020
ISBN: 978-0-12-820801-4
Verlag: William Andrew Publishing

Buch, Englisch, 340 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 680 g

Advances in Clinical Chemistry, Volume 94, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest technologies relating to the field of clinical chemistry, with specific chapters in this new release covering Hypertensive disorders of pregnancy: Strategy to develop clinical peptide biomarkers for more accurate evaluation of the pathophysiological status of this syndrome, Clotting factors - Clinical biochemistry and their roles as plasma enzymes, Myokines: The endocrine coupling of skeletal muscle and bone, Epigenetic reprogramming and potential application of epigenetic-modifying drugs in acquired chemotherapeutic resistance, and more.

Autoren/Hrsg.

Weitere Mitwirkende

Makowski, Gregory S.

Fachgebiete

• Naturwissenschaften Chemie Organische Chemie Biochemie
• Naturwissenschaften Chemie Chemie Allgemein Pharmazeutische Chemie, Medizinische Chemie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Biochemie (med.)

Inhaltsverzeichnis

1. Hypertensive disorders of pregnancy: Strategy to develop clinical peptide biomarkers for more accurate evaluation of the pathophysiological status of this syndrome Yoshihiko Araki and Mitsuaki Yanagida 2. Clotting factors - Clinical biochemistry and their roles as plasma enzymes William E. Winter, Dina N. Greene, Stacy G. Beal, James A. Isom, Heather Manning, Gloria Wilkerson and Neil Harris 3. Metabolomics in genetic testing Jacopo Troisi, Pierpaolo Cavallo, Angelo Colucci, Luca Pierri, Giovanni Scala, Steven Symes, Carter Jones and Sean Richards 4. Myokines: The endocrine coupling of skeletal muscle and bone Marta Gomarasca, Giuseppe Banfi and Giovanni Lombardi 5. Epigenetic reprogramming and potential application of epigenetic-modifying drugs in acquired chemotherapeutic resistance Logeswari Ponnusamy, Prathap Kumar S. Mahalingaiah and Kamaleshwar P. Singh 6. Organokines in disease Hye Soo Chung and Kyung Mook Choi

Über Autor(innen)

Makowski, Gregory S.
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.